M. Lahfa
Impact in
- Dermatology top 0.5%
- Dermatology and Skin Diseases
- Contact Dermatitis and Allergies
- Immunology top 2%
- Psoriasis: Treatment and Pathogenesis
Papers in
- Immunology 10
- Psoriasis: Treatment and Pathogenesis 10
- Biosimilars and Bioanalytical Methods 1
-
- Dermatology and Skin Diseases 7
- Contact Dermatitis and Allergies 3
- Dermatological and COVID-19 studies 1
- Co-authors
- P.C.M. van de Kerkhof (2 shared papers)C.E.M. Griffiths (2 shared papers)Stephen K. Tyring (1 shared paper)Ralph Zitnik (1 shared paper)Jörg C. Prinz (1 shared paper)Arline Nakanishi (1 shared paper)Kim Papp (1 shared paper)J. Berth‐Jones (2 shared papers)
- Journals
- British Journal of Dermatology (9 papers)Journal of the European Academy of Dermatology and Venereology (3 papers)Dermatology (2 papers)Journal of Allergy and Clinical Immunology (1 paper)Dermatology and Therapy (1 paper)
- Partner nations
- FranceGermanyNetherlands
In The Last Decade
M. Lahfa
20 papers receiving 1.6k citations
M. Lahfa's Hit Papers
Peers
Comparison fields: 5 of 71
- Dermatology 808
- Immunology 889
- Immunology and Allergy 228
- Rheumatology 171
- Hematology 89
Countries citing papers authored by M. Lahfa
This map shows the geographic impact of M. Lahfa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Lahfa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Lahfa more than expected).
Fields of papers citing papers by M. Lahfa
This network shows the impact of papers produced by M. Lahfa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Lahfa. The network helps show where M. Lahfa may publish in the future.
Co-authors
The 25 scholars most cited alongside M. Lahfa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A global phase III randomized controlled trial of etanercept in psoriasis: safety, efficacy, and effect of dose reduction Hit paper breakdown → | 2005 | 573 |
| 2 | 2008 | 267 | |
| 3 | 2002 | 190 | |
| 4 | 2008 | 145 | |
| 5 | 2004 | 97 | |
| 6 | 2006 | 70 | |
| 7 | 2014 | 46 | |
| 8 | 2014 | 44 | |
| 9 | 2005 | 44 | |
| 10 | 2013 | 43 | |
| 11 | 2009 | 34 | |
| 12 | 2012 | 29 | |
| 13 | 2011 | 23 | |
| 14 | 2013 | 21 | |
| 15 | 2013 | 16 | |
| 16 | 2011 | 5 | |
| 17 | 2017 | 5 | |
| 18 | 2021 | 5 | |
| 19 | 2018 | 4 | |
| 20 | 2014 | 3 |
About M. Lahfa
M. Lahfa is a scholar working on Immunology, Dermatology, Epidemiology, Infectious Diseases and Hematology, having authored 22 papers that have together received 1.7k indexed citations. Recurring topics across this work include Psoriasis: Treatment and Pathogenesis (10 papers), Dermatology and Skin Diseases (7 papers), Nail Diseases and Treatments (4 papers), Contact Dermatitis and Allergies (3 papers), Dermatological and COVID-19 studies (1 paper), Allergic Rhinitis and Sensitization (1 paper), Biosimilars and Bioanalytical Methods (1 paper) and Parvovirus B19 Infection Studies (1 paper). The work is most often cited by research in Dermatology (808 citations), Immunology (889 citations), Immunology and Allergy (228 citations), Rheumatology (171 citations) and Hematology (89 citations). M. Lahfa has collaborated with scholars based in France, Germany and Netherlands. Frequent co-authors include P.C.M. van de Kerkhof, C.E.M. Griffiths, Stephen K. Tyring, Ralph Zitnik, Jörg C. Prinz, Arline Nakanishi, Kim Papp, J. Berth‐Jones, F. Cambazard and Thomas L. Diepgen. Their work appears in journals such as British Journal of Dermatology, Journal of the European Academy of Dermatology and Venereology, Dermatology, Journal of Allergy and Clinical Immunology and Dermatology and Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.